Triological Society Best Practice
What are the best management strategies for radiation-induced xerostomia?
Scott E. Strome, MD, is a cofounder and major stockholder in Gliknik, Inc., a biotechnology company. Dr. Strome also receives royalties from the Mayo Clinic College of Medicine for the licensure of intellectual property related to B7-H1 and 4-1BB to third parties. The authors have no other funding, financial relationships, or conflicts of interest to disclose.
No abstract is available for this article.